Prdx5 regulates macrophage polarization by modulating the TLR4/NF-κB pathway to promote apoptosis in chronic prostatitis
International Immunopharmacology · 2025-04 · 151 · 114332
DOI: 10.1016/j.intimp.2025.114332 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-04. Verfasst von Weikang Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Anhui Medical University, Institute of Urology, and Anhui Province Key Laboratory of Urologic…. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Prostatitis, NF-kappa B, Macrophages. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Anhui Provincial Key Research and Development Plan, National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent urological disorder characterized by urinary symptoms, pelvic pain, and sexual dysfunction. Despite its high prevalence, the pathogenesis of CP/CPPS remains poorly understood. Our study revealed that peroxiredoxin 5 (Prdx5) was upregulated in M1 macrophages and in mice with experimental autoimmune prostatitis (EAP), with its expression in macrophages being regulated in a reactive oxygen species (ROS)-dependent manner. Using western blotting, RT-qPCR, immunohistochemical staining, hematoxylin and eosin staining, immunofluorescence staining, flow cytometry, and cell co-culturing, it was demonstrated that the silencing of Prdx5 suppressed the polarization of macrophages towards the M1 phenotype. This inhibition reduced apoptosis in prostate epithelial cells and mitigated the progression of EAP. Furthermore, Prdx5 mediated its effects in macrophages and EAP via the Toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) pathway. Our findings suggest that Prdx5 promoted the occurrence and development of CP/CPPS due to its promotion of M1 polarization and apoptosis of prostate epithelial cells in an ROS-dependent manner via the TLR4/NF-κB axis, indicating its potential as a therapeutic target to treat CP/CPPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Anhui Medical University, Institute of Urology, and Anhui Province Key Laboratory of Urological and Andrological Diseases Research and Medical Transformation, Anhu…
Förderung
- Anhui Provincial Key Research and Development Plan
- National Natural Science Foundation of China
Zitieren
APA
Wu, W., Meng, T., Wang, Y., Chen, J., & Liang, C. (2025). Prdx5 regulates macrophage polarization by modulating the TLR4/NF-κB pathway to promote apoptosis in chronic prostatitis. International Immunopharmacology, 151, 114332. https://doi.org/10.1016/j.intimp.2025.114332
Vancouver
Wu W, Meng T, Wang Y, Chen J, Liang C. Prdx5 regulates macrophage polarization by modulating the TLR4/NF-κB pathway to promote apoptosis in chronic prostatitis. International Immunopharmacology. 2025;151:114332. doi:10.1016/j.intimp.2025.114332
BibTeX
@article{Wu2025,
author = {Wu, Weikang and Meng, Tong and Wang, Yufan and Chen, Jing and Liang, Chaozhao},
title = {Prdx5 regulates macrophage polarization by modulating the TLR4/NF-κB pathway to promote apoptosis in chronic prostatitis},
journal = {International Immunopharmacology},
year = {2025},
volume = {151},
pages = {114332},
doi = {10.1016/j.intimp.2025.114332}
}
EUVIMED